Sign in

CIK 0001787297 · Non-accelerated filer<br>Smaller reporting company

Passage BIO, Inc.

Sign in to watch
Ticker
PASG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822729751
Phone
2678660312
Business address
ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA, PA, 19103
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-03-03 Ratcliffe Liam Director Conversion +2,066,630 2,066,630
2020-03-03 Ratcliffe Liam Director Purchase +550,000 $18.00 $9.9M 2,616,630
2020-03-03 Ratcliffe Liam Director Purchase +2,800 $18.00 $50K 2,800
2020-03-03 Ratcliffe Liam Director Conversion · Series B Preferred Stock −2,066,630 0
2020-03-03 ORBIMED ADVISORS LLC 10% owner Conversion +3,721,552 4,094,852
2020-03-03 ORBIMED ADVISORS LLC 10% owner Conversion +1,311,469 5,406,321
2020-03-03 ORBIMED ADVISORS LLC 10% owner Conversion +541,002 5,947,323
2020-03-03 ORBIMED ADVISORS LLC 10% owner Conversion · Series A-1 Preferred Stock −3,721,552 0
2020-03-03 ORBIMED ADVISORS LLC 10% owner Conversion · Series A-2 Preferred Stock −1,311,469 0
2020-03-03 ORBIMED ADVISORS LLC 10% owner Conversion · Series B Preferred Stock −541,002 0
2020-03-03 Versant Venture Capital VI, L.P. 10% owner Conversion +2,977,242 2,977,242
2020-03-03 Versant Venture Capital VI, L.P. 10% owner Conversion +1,049,175 4,026,417
2020-03-03 Versant Venture Capital VI, L.P. 10% owner Conversion +708,352 708,352
2020-03-03 Versant Venture Capital VI, L.P. 10% owner Purchase +225,000 $18.00 $4.0M 933,352
2020-03-03 Versant Venture Capital VI, L.P. 10% owner Conversion · Series A-1 Preferred Stock −2,977,242 0
2020-03-03 Versant Venture Capital VI, L.P. 10% owner Conversion · Series A-2 Preferred Stock −1,049,175 0
2020-03-03 Versant Venture Capital VI, L.P. 10% owner Conversion · Series B Preferred Stock −708,352 0
2020-03-03 Frazier Life Sciences IX, L.P. 10% owner Conversion +2,977,242 2,977,242
2020-03-03 Frazier Life Sciences IX, L.P. 10% owner Conversion +1,049,175 4,026,417
2020-03-03 Frazier Life Sciences IX, L.P. 10% owner Conversion +432,802 4,459,219

Page 11 of 14 · 264 trades